Sylvan Group recently made headlines after announcing that it is investing US$140.5 million to take majority stakes in four healthcare and pharmaceutical companies in Singapore. Kyungsun Chung, Co-Founder & Managing Partner, The Sylvan Group shares why the group has a particular core focus on impact investing and what goes behind the selection process in his company when choosing a company to invest in. 

Sylvan Group recently made headlines after announcing that it is investing US$140.5 million to take majority stakes in four healthcare and pharmaceutical companies in Singapore.&nbsp;Kyungsun Chung, Co-Founder &amp; Managing Partner, The Sylvan Group&nbsp;shares why the group has a particular core focus on impact investing and what goes behind the selection process in his company when choosing a company to invest in.&nbsp;

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Advertisement